- Health & Pharmaceuticals›
- Health System›
Medicare reimbursements of inpatient charges in the U.S. by condition 2016
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Medicare reimbursements of inpatient charges in the U.S. by condition 2016
Percent of inpatient charges reimbursed by Medicare by select condition in 2016*
This statistic displays the percentage of inpatient charges for acute-care hospitals that were reimbursed by Medicare in the United States in 2016, by select condition. In that year, diabetes mellitus inpatients in not-for profit hospitals were reimbursed 26 percent of their charges by Medicare.
Percent of inpatient charges reimbursed by Medicare by select condition in 2016*
| Not-for-Profit | For-Profit | Government | |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Not-for-Profit | For-Profit | Government | |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic displays the percentage of inpatient charges for acute-care hospitals that were reimbursed by Medicare in the United States in 2016, by select condition. In that year, diabetes mellitus inpatients in not-for profit hospitals were reimbursed 26 percent of their charges by Medicare.
Show more- Show sources information
- Show publisher information
- Release date
- 2018
- Region
- United States
- Survey time period
- 2016
- Special properties
- acute-care hospitals
- Supplementary notes
- * Data in 2016 vary from previous years due to the mandatory implementation of ICD-10 coding beginning October 1, 2015, which resulted in additional diagnoses being captured in the 2016 data for some of the disease states shown. For details, see the methodology on pages 60-61. Unless otherwise specified, data include cases for primary and secondary diagnoses.
Source
- Show sources information
- Show publisher information
- Release date
- 2018
More information
- Region
- United States
- Survey time period
- 2016
- Special properties
- acute-care hospitals
- Supplementary notes
- * Data in 2016 vary from previous years due to the mandatory implementation of ICD-10 coding beginning October 1, 2015, which resulted in additional diagnoses being captured in the 2016 data for some of the disease states shown. For details, see the methodology on pages 60-61. Unless otherwise specified, data include cases for primary and secondary diagnoses.
Other statistics on the topic
Prostate cancer in the U.S.
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Prostate cancer in the U.S.
- 75 page/s
- English
- pptx
- Detailed references
Everything On "Prostate cancer in the U.S." in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Prostate cancer in the U.S."
- Overview
The most important statistics
- Percentage of men in the U.S. with prostate cancer who were diagnosed at select stages as of 2018Stage at diagnosis among U.S. men with prostate cancer as of 2018
- Percentage of men in the U.S. with prostate cancer who stated prostate cancer had select impacts on their quality of life as of 2018Impacts of prostate cancer on life quality among U.S. men as of 2018
- Percentage of men in the U.S. with prostate cancer who stated select symptoms affected their daily life as of 2018Symptoms of prostate cancer that affected the daily lives of U.S. men as of 2018
- Incidence
The most important statistics
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)United States: incidence rates for cancer 2011-2015, by gender
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*U.S. number of cancer cases among men in 2009 and 2019
- Incidence rate of prostate cancer in the U.S. from 2011 to 2015, by ethnicity (per 100,000 population)Rate of prostate cancer among U.S. males 2011-2015, by ethnicity
- Number of new prostate cancer cases in the U.S. in 2015, by state (per 100,000 population)Prostate cancer incidence rate in the U.S. in 2015, by state
- Probability of developing prostate cancer in the U.S. from 2013 to 2015, by age Chance of developing prostate cancer in the U.S. 2013-2015, by age
- Survival rates
The most important statistics
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancerCancer: 5-year survival rates in the U.S. 2008-2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014Five-year survival rates for prostate and testicular cancer U.S. 1975-2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 2008 to 2014, by stage at diagnosisFive-year survival rates for prostate and testicular cancer U.S. 2008-2014, by stage
- Deaths
The most important statistics
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by diseasePercentage changes in selected causes of death in the U.S. 2000-2017
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)U.S. death rates from cancer by type and gender 2012-2016
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer typeU.S. number of cancer deaths among men 2009 and 2019
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by prostate cancer in the U.S. 1950-2016
- Number of deaths due to prostate cancer in the United States from 1999 to 2015Number of deaths due to prostate cancer in U.S. 1999-2015
- Death rate for prostate cancer in the U.S. from 2012 to 2016, by ethnicity (per 100,000 population)Prostate cancer death rate in the U.S. 2012-2016, by ethnicity
- Number of prostate cancer deaths in the U.S. in 2015, by state (per 100,000 population)Prostate cancer death rate in the U.S. in 2015, by state
- Screening
The most important statistics
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ageProstate cancer test among men aged 50 years and older in the U.S. 2015, by age
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ethnicityProstate cancer test among men aged 50 years and older in the U.S. 2015, by ethnicity
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by educationProstate cancer test among men aged 50 years and older in the U.S. 2015, by education
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by regionProstate cancer test among men aged 50 years and older in the U.S. 2015, by region
- Treatment
The most important statistics
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012Distribution of treatment types for prostate cancer 2010-2012
- Medicines in development for cancer in the United States as of 2018, by all types*Medicines in development for cancer in the United States 2018
- Out-of-pocket costs per Medicare Part D retail prescription by therapy area in 2018 (in U.S. dollars)*Out of pocket costs of Medicare Part D retail prescription by drug therapy 2018
- Hospital care
The most important statistics
- Number of inpatient and outpatient cases per U.S. hospital by selected disease in 2016*Average inpatient and outpatient cases per hospital in the U.S. by disease 2016
- Average length of Medicare inpatient hospital stays by disease in 2016, by IDN status (in days)*Medicare inpatient hospital ALOS in U.S. cases by disease and IDN status 2016
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2016 (in days)Inpatient average length of stay in U.S. hospitals by cancer type 2008-2016
- Distribution of inpatient cases per hospital in the United States in 2016, by payer type and disease*Inpatient case share per U.S. hospital by insurance type and disease 2016
- Percent of inpatient charges reimbursed by Medicare by select condition in 2016*Medicare reimbursements of inpatient charges in the U.S. by condition 2016
- Average charge per inpatient case in U.S. acute-care hospitals by condition in 2016 (in U.S. dollars)*Charges for inpatients in U.S. hospitals per case by condition 2016
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Share of inpatient cases in the U.S. by gender and selected disease 2014
- Medicare hospital inpatient stay patient characteristics in MA and FFS plan 2013
- Opioid-related inpatient stays under Medicare U.S. 2010 and 2015, by state
- Percentage of inpatient prostate cancer cases in the U.S. by payer 2007-2012
- Annual facility charges for multiple sclerosis patients in the U.S. by region 2012
- Inpatient and outpatient MS cases per hospital in U.S. 2014-2016
- Share of inpatient MS cases in the U.S. by demographic 2012
- Hospital stays with leading operating room procedure paid by Medicare 2012
- Medicare hospital inpatient case charges by severity in the U.S. 2014
- Medicare hospital inpatient charges by disease in the U.S. 2016
- Compensation for U.S. physicians under Medicare HMOs by method 2015
- Annual inpatient charges for Medicaid type 2 diabetes patients 2016
- Medicare Part D payer share of branded and generic drugs by therapy area 2015
- Expenditures on healthcare in the UAE by type 2017
- Managed Care percentage in the U.S. of total Medicare spending 2004-2017
- Italy: number of deceased patients with neoplastic diseases 2016, by department
- Health expenditure on inpatient curative and rehabilitative care in Lithuania 2004-13
- Share of children registered with appropriate immunization Australia 2014-2016 by age
- Inpatient curative and rehabilitative care: GDP expenditure in Greece 2009-2013
- Italy: number of deceased patients with neoplastic diseases 2016, by region
Statistics on "Prostate cancer in the U.S."
- Percentage of men in the U.S. with prostate cancer who were diagnosed at select stages as of 2018
- Percentage of men in the U.S. with prostate cancer who stated prostate cancer had select impacts on their quality of life as of 2018
- Percentage of men in the U.S. with prostate cancer who stated select symptoms affected their daily life as of 2018
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*
- Incidence rate of prostate cancer in the U.S. from 2011 to 2015, by ethnicity (per 100,000 population)
- Number of new prostate cancer cases in the U.S. in 2015, by state (per 100,000 population)
- Probability of developing prostate cancer in the U.S. from 2013 to 2015, by age
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancer
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 2008 to 2014, by stage at diagnosis
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by disease
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer type
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)
- Number of deaths due to prostate cancer in the United States from 1999 to 2015
- Death rate for prostate cancer in the U.S. from 2012 to 2016, by ethnicity (per 100,000 population)
- Number of prostate cancer deaths in the U.S. in 2015, by state (per 100,000 population)
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by age
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ethnicity
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by education
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by region
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012
- Medicines in development for cancer in the United States as of 2018, by all types*
- Out-of-pocket costs per Medicare Part D retail prescription by therapy area in 2018 (in U.S. dollars)*
- Number of inpatient and outpatient cases per U.S. hospital by selected disease in 2016*
- Average length of Medicare inpatient hospital stays by disease in 2016, by IDN status (in days)*
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2016 (in days)
- Distribution of inpatient cases per hospital in the United States in 2016, by payer type and disease*
- Percent of inpatient charges reimbursed by Medicare by select condition in 2016*
- Average charge per inpatient case in U.S. acute-care hospitals by condition in 2016 (in U.S. dollars)*
- Distribution of inpatient cases by selected disease in the United States in 2014, by gender
- Medicare Advantage versus fee-for-service plan inpatient hospital stays in 2013, by patient characteristics
- Share of opioid-related inpatient stays under Medicare in the U.S. in 2010 and 2015, by state
- Distribution of inpatient prostate cancer cases in the United States from 2007 to 2012, by payer
- Annual facility charges for U.S. multiple sclerosis patients in 2012, by region (in U.S. dollars)
- Number of inpatient and outpatient multiple sclerosis cases per hospital in the U.S. from 2014 to 2016
- Distribution of inpatient cases of multiple sclerosis in the United States in 2012, by demographic group
- Total hospital stays with most frequent operating room procedures paid through Medicare in the United States in 2012
- Medicare hospital inpatient charges per selected case by severity in 2014 (in U.S. dollars)*
- Medicare hospital inpatient charges by select condition in 2016 (in U.S. dollars)*
- Distribution of compensation methods for U.S. physicians under Medicare HMOs in 2015*
- Average inpatient charges for Medicaid patients with type 2 diabetes in Florida, New York, and nationwide from 2014 to 2016 (in U.S. dollars)*
- Medicare Part D payer share of branded and generic drugs by therapy area in 2015
- Healthcare expenditures in the United Arab Emirates in 2017, by type (in billion U.S. dollars)*
- Percentage of managed care within total Medicare expenditures from 2004 to 2017
- Number of patients with neoplastic diseases deceased in inpatient care in Italy in 2016, by department
- Share of current health expenditure on inpatient curative and rehabilitative care in Lithuania from 2004 to 2013
- Percentage of children registered with appropriate immunization coverage in Australia from the financial year 2013/14 to 2015/2016, by age
- Share of GDP spending on inpatient curative and rehabilitative care in Greece from 2009 to 2013
- Number of patients with neoplastic diseases deceased in inpatient care in Italy in 2016, by region
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.